Growth Metrics

Marimed (MRMD) Depreciation & Amortization (CF) (2016 - 2025)

Marimed has reported Depreciation & Amortization (CF) over the past 10 years, most recently at $2.1 million for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) fell 4.07% to $2.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.1 million through Dec 2025, up 2.52% year-over-year, with the annual reading at $8.1 million for FY2025, 2.52% up from the prior year.
  • Depreciation & Amortization (CF) was $2.1 million for Q4 2025 at Marimed, down from $2.1 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $2.2 million in Q4 2024 and troughed at $462000.0 in Q1 2021.
  • The 5-year median for Depreciation & Amortization (CF) is $1.4 million (2023), against an average of $1.4 million.
  • Year-over-year, Depreciation & Amortization (CF) soared 96.55% in 2024 and then dropped 6.76% in 2025.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $600682.0 in 2021, then skyrocketed by 60.32% to $963000.0 in 2022, then soared by 77.67% to $1.7 million in 2023, then increased by 26.3% to $2.2 million in 2024, then fell by 4.07% to $2.1 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Depreciation & Amortization (CF) are $2.1 million (Q4 2025), $2.1 million (Q3 2025), and $2.1 million (Q2 2025).